spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Clostridium difficile 

 HSMN NewsFeed - 20 Jul 2021
First Light Diagnostics Receives FDA Clearance for its Rapid Clostridiodes difficile Test on the MultiPath(R) Analyzer
Diagnostics FDA
 HSMN NewsFeed - 18 Jun 2020
Almirall Announces FDA Approval Of Updated Label For Seysara(R) (Sarecycline) Tablets
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 12 Jun 2019
CutisPharma Announces Acquisition Of Silvergate Pharmaceuticals, Name Change To Azurity Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Mar 2019
Allergan Announces FDA Approval of AVYCAZ(R) (ceftazidime and avibactam) for Pediatric Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Jan 2019
Magnolia Medical Announces $20 Million Series C Financing
Devices Venture Capital Personnel
 HSMN NewsFeed - 15 Jan 2019
CutisPharma Announces New Management Team Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2018
FDA Approves AVYCAZ(R) (ceftazidime and avibactam) for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Nov 2017
GenePOC Launches its GenePOC(TM) CDiff Test in the United States
Diagnostics FDA Product Launch
 HSMN NewsFeed - 24 Jul 2017
Luminex Corporation Receives FDA Clearance for ARIES C. difficile Assay
Diagnostics FDA
 HSMN NewsFeed - 1 Jun 2017
GenePOC Announces FDA Clearance for Revogene(TM) Instrument and its GBS LB Test
Diagnostics FDA
 HSMN NewsFeed - 3 May 2017
Luminex Corporation Receives FDA Clearance for ARIES Bordetella Assay
Diagnostics FDA
 HSMN NewsFeed - 30 Jan 2017
AmpliPhi Biosciences Appoints Dr. Igor P. Bilinsky as Senior Vice President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2016
Teva Strengthens Injectables Portfolio with the Launch of an Authorized Generic of Cubicin(R) (Daptomycin for Injection) in the United States
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 23 Jun 2016
Allergan Announces FDA Approval of Supplemental New Drug Application (sNDA) for AVYCAZ(R) (ceftazidime and avibactam)
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 May 2016
Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Feb 2016
FDA Accepts and Grants Priority Review for AVYCAZ(R) (ceftazidime and avibactam) Supplemental New Drug Application (sNDA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Feb 2016
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO(R) (ceftaroline fosamil)
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Jan 2016
Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for DALVANCE(R) (dalbavancin)
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Jan 2016
HiberGene Closes First Tranche of Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 21 Dec 2015
Oral REVLIMID(R) Plus Dexamethasone Granted Approval for Treatment of Patients with Newly Diagnosed Multiple Myeloma in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Nov 2015
Seres Therapeutics Appoints Kurt Graves to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Aug 2015
Baxter and Water Street Announce FDA Approval of CEFAZOLIN 2 Gram Premix
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 May 2015
Roche receives FDA clearance for the cobas(R) Cdiff Test to detect Clostridium difficile
Diagnostics FDA
 HSMN NewsFeed - 22 Apr 2015
Great Basin Receives FDA 510(k) Clearance for Group B Strep Molecular Diagnostic Test
Diagnostics FDA
 HSMN NewsFeed - 23 Jan 2015
The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(TM) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Jan 2015
Seres Health Appoints Shelley Trucksis, Ph.D., M.D. as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jul 2014
Aqua Pharmaceuticals, LLC Announces the U.S. Food and Drug Administration (FDA) Approval of ACTICLATE(TM) (doxycycline hyclate USP) Tablets, 150 mg and 75 mg
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Dec 2013
Quidel Receives FDA Clearance for Its Hand-Held Molecular Diagnostic Test - AmpliVue(R) Group B Strep Assay
Diagnostics FDA
 HSMN NewsFeed - 15 Nov 2013
Germ-Zapping Robots Use Xenex’s Powerful, Pulsed UV Light to Improve Patient Safety at University Hospital
Devices
 HSMN NewsFeed - 11 Nov 2013
Shire to Acquire ViroPharma in Strategic Move to Strengthen Rare Disease Portfolio; Will Augment Already Strong Growth Prospects
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Nov 2013
Eisai Announces Availability of ACIPHEX(R) Sprinkle(TM) (Rabeprazole Sodium) for Treatment of GERD in Children Ages 1 to 11
Biopharmaceuticals Gastroenterology Product Launch
 HSMN NewsFeed - 9 Oct 2013
Covenant Health Deploys Powerful Superbug-Slaying Robot for Room Disinfection
Devices
 HSMN NewsFeed - 18 Jul 2013
Celgene Will Discontinue Phase III ORIGIN(R) Trial in Previously Untreated Elderly Patients with B-Cell Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Jul 2013
Sequella Acquires Exclusive Worldwide Rights to Pfizer’s Sutezolid, Currently in Clinical Development for Tuberculosis
Biopharmaceuticals Licensing
 HSMN NewsFeed - 13 May 2013
Optimer Pharmaceuticals Appoints Eric Sirota as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Feb 2013
FDA Grants QIDP and Fast Track Designations for Cubist’s Late-Stage Antibiotic Candidates
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Feb 2013
Ritter Pharmaceuticals Names Larry Good, M.D. Chief Medical Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 19 Nov 2012
Abacus Diagnostica Receives CE Mark for its Rapid Direct PCR Test for Toxigenic Clostridium Difficile
Diagnostics Regulatory
 HSMN NewsFeed - 4 Sep 2012
Two New Executives Join VaxInnate Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Aug 2012
Astellas Pharma Europe Ltd. Appoints Dr Susan Wood as Senior Director, Market Access
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2012
Optimer Pharmaceuticals Appoints Stephen Newman to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jun 2012
ConvaTec Introduces Enhanced Flexi-Seal(R) SIGNAL(R) FMS
Devices
 HSMN NewsFeed - 9 Apr 2012
Optimer Pharmaceuticals Announces Personnel Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Feb 2012
PaxVax Expands Executive Management Team
Biopharmaceuticals HIV/AIDS Personnel
 HSMN NewsFeed - 12 Jan 2012
Chief Operating Officer Tessie M. Che Departing Company
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2011
Astellas and Theravance Announce European Marketing Authorization for VIBATIV(R) for Nosocomial Pneumonia Caused by MRSA
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 May 2011
Optimer Pharmaceuticals Expands Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2011
Optimer Pharmaceuticals Appoints Glenn Tillotson, Ph.D., to Senior Vice President of Medical Affairs and Announces Executive Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jan 2011
Optimer Pharmaceuticals Announces Key Additions to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Dec 2010
Cubist Pharmaceuticals Receives FDA Approval for 2-Minute IV Injection of CUBICIN
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Oct 2010
Forest Announces FDA Approval of Teflaro(TM) (ceftaroline fosamil) for the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Sep 2010
Cubist Pharmaceuticals Announces Promotion of Steven C. Gilman, Ph.D., to EVP, Research and Development and Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jun 2010
Salix Pharmaceuticals Announces NDA Submission For XIFAXAN550 For Treatment of Non-Constipation Irritable Bowel Syndrome
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 24 Mar 2010
FDA Approves XIFAXAN(R) 550 MG Tablets for Reduction in Risk of Overt Hepatic Encephalopathy (HE) Recurrence
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Feb 2010
ConvaTec Introduces Flexi-Seal(R)(TM) SIGNAL(TM) FMS
Devices
 HSMN NewsFeed - 11 Feb 2010
Excelimmune Receives $1 Million in Series-B Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Jan 2010
ViroPharma Expands Global Licensing, Commercialization and Development Rights for Cinryze(TM) (C1 esterase inhibitor [human])
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 Dec 2009
Nanotherapeutics Acquires Two Late Stage Clinical Programs for Alzheimer's Treatment and CDA Disease
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 14 Dec 2009
Cubist Pharmaceuticals to Acquire Calixa Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Dec 2009
Trial Date Set for CUBICIN(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 27 Nov 2009
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Nov 2009
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
Biopharmaceuticals
 HSMN NewsFeed - 29 Oct 2009
FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Diagnostics FDA
 HSMN NewsFeed - 6 Oct 2009
Gen-Probe to Acquire Prodesse, Leader in Molecular Testing for Respiratory Infectious Diseases, for $60 Million in Cash Plus Potential Milestone Payments
Diagnostics Acquisitions
 HSMN NewsFeed - 1 Oct 2009
Astellas and Theravance Announce Approval of VIBATIV(TM) (telavancin) in Canada for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Jul 2009
Cepheid Receives FDA Clearance for First On-Demand Molecular Diagnostic Test for Clostridium difficile Infection
Diagnostics FDA
 HSMN NewsFeed - 8 Jun 2009
ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2009
Positive Results from Salix Pivotal Phase III Study of Rifaximin for the Prevention and Maintenance of Remission of Hepatic Encephalopathy (HE) Presented at Digestive Disease Week (DDW)
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 21 Apr 2009
Merck & Co., Inc., Medarex, Inc. and Massachusetts Biologic Laboratories Sign Exclusive Licensing Agreement for Investigational Monoclonal Antibody Combination for Clostridium Difficile Infection
Biopharmaceuticals Licensing
 HSMN NewsFeed - 30 Mar 2009
Inverness Medical Innovations Launches New FDA Cleared C. DIFF QUIK CHEK COMPLETE(TM) Rapid Test
Diagnostics
 HSMN NewsFeed - 24 Mar 2009
FDA Approves New Indication for Wyeth's TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Feb 2009
ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
Biopharmaceuticals
 HSMN NewsFeed - 9 Feb 2009
ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
Biopharmaceuticals
 HSMN NewsFeed - 3 Feb 2009
FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Jan 2009
The Medicines Company to Acquire Targanta Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Jan 2009
BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
Diagnostics FDA
 HSMN NewsFeed - 2 Dec 2008
Cubist Names Santosh J. Vetticaden as SVP, Clinical Development and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Nov 2008
Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
Diagnostics
 HSMN NewsFeed - 21 Oct 2008
ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Aug 2008
Replidyne Announces Restructuring of Operations
Biopharmaceuticals
 HSMN NewsFeed - 30 Jul 2008
Oscient Pharmaceuticals Promotes Mark A. Glickman to Senior Vice President, Sales and Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2008
ViroPharma To Acquire Lev Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Jul 2008
BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections
Diagnostics Regulatory
 HSMN NewsFeed - 2 Jul 2008
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V.
Biopharmaceuticals
 HSMN NewsFeed - 29 May 2008
Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 May 2008
ConvaTec Upgrades Flexi-Seal(R) Fecal Management System to Increase Ease of Use
Devices Wound Care
 HSMN NewsFeed - 24 Apr 2008
Dyax Corp. and Cubist Pharmaceuticals, Inc. Sign Development and Commercialization Agreement for DX-88 Surgical Indications
Biopharmaceuticals
 HSMN NewsFeed - 4 Mar 2008
Cardinal Health Agrees to Acquire ChloraPrep(R) Manufacturer for $490 Million
Devices Mergers & Acquisitions
 HSMN NewsFeed - 12 Feb 2008
Cubist Pharmaceuticals Names Steven C. Gilman, Ph.D., as Senior Vice President, Discovery and Non-Clinical Development and Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jan 2008
Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
Diagnostics Regulatory
 HSMN NewsFeed - 24 Jan 2008
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Jan 2008
ViroPharma Provides Update on Vancocin(R)
Biopharmaceuticals
 HSMN NewsFeed - 3 Jan 2008
ViroPharma Augments Senior Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jan 2008
BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
Diagnostics FDA
 HSMN NewsFeed - 26 Dec 2007
Cubist Pharmaceuticals Acquires Illumigen Biosciences
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Nov 2007
ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Oct 2007
FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
Biopharmaceuticals
 HSMN NewsFeed - 16 Oct 2007
Cubist Pharmaceuticals Announces Exclusive Option to Acquire Illumigen Biosciences
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Oct 2007
FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections
Biopharmaceuticals Urology FDA
 HSMN NewsFeed - 17 Sep 2007
FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
Biopharmaceuticals Urology FDA
 HSMN NewsFeed - 6 Sep 2007
Cubist Pharmaceuticals' CUBICIN Approved for Additional Indications in the EU
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Aug 2007
Cubist Pharmaceuticals Creates COO Position, Adds Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Aug 2007
Oscient Pharmaceuticals Names Aaron D. Berg Vice President of Marketing and Mark A. Glickman Vice President of Sales
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jul 2007
ViroPharma Announces Key Additions to European Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jul 2007
Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Biopharmaceuticals
 HSMN NewsFeed - 5 Jul 2007
ViroPharma Initiates Phase 3 Study of CAMVIA(TM) (maribavir) in Liver Transplant Patients
Biopharmaceuticals
 HSMN NewsFeed - 27 Jun 2007
FDA Grants Fast Track Status for HCV-796 for Treatment of Hepatitis C Virus Infection
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Jun 2007
July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of FACTIVE(R) Tablets for Five-Day Treatment of Community-Acquired Pneumonia
Biopharmaceuticals
 HSMN NewsFeed - 17 May 2007
FDA Advisory Committee Unanimously Votes in Favor of Acambis' Smallpox Vaccine
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 May 2007
FDA Approves Oscient Pharmaceuticals' FACTIVE(R) Tablets for Five-Day Treatment of Community-Acquired Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 May 2007
Robert G. Pietrusko Joins ViroPharma as Vice President of Global Regulatory Affairs and Quality
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 May 2007
ViroPharma Announces Decision To Develop And Commercialize Maribavir In Europe
Biopharmaceuticals
 HSMN NewsFeed - 30 Apr 2007
3M, Gen-Probe Form Collaboration to Develop Rapid Molecular Tests to Combat Healthcare-Associated Infections
Diagnostics
 HSMN NewsFeed - 25 Apr 2007
BD Announces FDA 510(k) Submission of Two Hour Test to Identify Superbug in Patients with Positive Blood Cultures
Diagnostics FDA
 HSMN NewsFeed - 2 Mar 2007
Abbott Canada Launches Oscient Pharmaceuticals' FACTIVE Tablets in Canada
Biopharmacetuicals
 HSMN NewsFeed - 22 Feb 2007
New Treatment Guidelines for Community-Acquired Pneumonia Highlight Utility of FACTIVE Tablets
Biopharmaceuticals
 HSMN NewsFeed - 12 Feb 2007
sanofi-aventis Announces Update to U.S. Prescribing Information for Ketek(R) (Telithromycin)
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Feb 2007
ViroPharma Receives Orphan Drug Designation for Maribavir for Cytomegalovirus Viremia and Disease Indication
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Jan 2007
Oscient Pharmaceuticals Completes Enrollment in Phase IV Trial of FACTIVE Tablets
Biopharmaceuticals
 HSMN NewsFeed - 29 Dec 2006
Oscient Pharmaceuticals Amends FACTIVE License Agreement with LG Life Sciences
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Nov 2006
FDA Accepts as "Complete Response" Oscient Pharmaceuticals' Submission Following FACTIVE Approvable Letter for Five-Day CAP
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Nov 2006
Daniel B. Soland Joins ViroPharma as Vice President and Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Oct 2006
Cepheid Extends European Product Line With Launch of Xpert(TM) MRSA Test for GeneXpert(R) System
Diagnostics
 HSMN NewsFeed - 23 Oct 2006
Salix Pharmaceuticals Reports American College of Gastroenterology Update
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 13 Oct 2006
Data on FACTIVE(R) Tablets Short-Course Therapy in Patients with Co-Morbidities Presented at Annual Meeting of Infectious Diseases Society of America
Biopharmaceuticals
 HSMN NewsFeed - 5 Oct 2006
Oscient Pharmaceuticals and Pfizer, S.A. de C.V. Announce Launch of FACTIVE(R) Tablets in Mexico
Biopharmaceuticals
 HSMN NewsFeed - 28 Sep 2006
United States Seeing Greater Increases in Clostridium Difficile-Associated Disease Case-Load and Severity
Biopharmaceuticals
 HSMN NewsFeed - 28 Sep 2006
ViroPharma Initiates First of Two Phase 3 Studies of Maribavir in Transplant Patients
Biopharmaceuticals
 HSMN NewsFeed - 22 Sep 2006
Oscient Pharmaceuticals Receives Approvable Letter from FDA for FACTIVE(R) Tablets for Five-Day Treatment of Community-Acquired Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Sep 2006
Oscient Pharmaceuticals Announces Results of FDA Advisory Committee Meeting for FACTIVE Tablets for the Treatment of Acute Bacterial Sinusitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Jun 2006
Oscient Pharmaceuticals Announces Meeting Date for FDA Advisory Committee to Address sNDA for Five-Day Treatment of Acute Bacterial Sinusitis with FACTIVE Tablets
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 May 2006
Oscient Pharmaceuticals Hires Philippe M. Maitre as Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 May 2006
Acambis announces forthcoming retirement of Chief Scientific Officer
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 48

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 48 additional stories matching:
Clostridium difficile
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.